Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.09
AMS's Cash-to-Debt is ranked lower than
77% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 0.49 vs. AMS: 0.09 )
Ranked among companies with meaningful Cash-to-Debt only.
AMS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.23 Max: N/A
Current: 0.09
Equity-to-Asset 0.36
AMS's Equity-to-Asset is ranked lower than
69% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. AMS: 0.36 )
Ranked among companies with meaningful Equity-to-Asset only.
AMS' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.58  Med: 0.31 Max: 0.43
Current: 0.36
-0.58
0.43
Interest Coverage 1.89
AMS's Interest Coverage is ranked lower than
85% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 8.43 vs. AMS: 1.89 )
Ranked among companies with meaningful Interest Coverage only.
AMS' s Interest Coverage Range Over the Past 10 Years
Min: 0.32  Med: 0.62 Max: 1.93
Current: 1.89
0.32
1.93
Piotroski F-Score: 8
Altman Z-Score: 1.09
Beneish M-Score: -2.82
WACC vs ROIC
11.97%
4.75%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 18.28
AMS's Operating Margin % is ranked higher than
85% of the 266 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. AMS: 18.28 )
Ranked among companies with meaningful Operating Margin % only.
AMS' s Operating Margin % Range Over the Past 10 Years
Min: -0.32  Med: 6.76 Max: 18.28
Current: 18.28
-0.32
18.28
Net Margin % 6.05
AMS's Net Margin % is ranked higher than
59% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.39 vs. AMS: 6.05 )
Ranked among companies with meaningful Net Margin % only.
AMS' s Net Margin % Range Over the Past 10 Years
Min: -9.2  Med: 0.28 Max: 6.05
Current: 6.05
-9.2
6.05
ROE % 5.59
AMS's ROE % is ranked lower than
66% of the 249 Companies
in the Global Medical Care industry.

( Industry Median: 9.35 vs. AMS: 5.59 )
Ranked among companies with meaningful ROE % only.
AMS' s ROE % Range Over the Past 10 Years
Min: -7.33  Med: 0.24 Max: 5.59
Current: 5.59
-7.33
5.59
ROA % 1.95
AMS's ROA % is ranked lower than
64% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.86 vs. AMS: 1.95 )
Ranked among companies with meaningful ROA % only.
AMS' s ROA % Range Over the Past 10 Years
Min: -2.5  Med: 0.07 Max: 1.95
Current: 1.95
-2.5
1.95
ROC (Joel Greenblatt) % 9.85
AMS's ROC (Joel Greenblatt) % is ranked lower than
63% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 16.56 vs. AMS: 9.85 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AMS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.97  Med: 5.59 Max: 9.85
Current: 9.85
1.97
9.85
3-Year Revenue Growth Rate -4.30
AMS's 3-Year Revenue Growth Rate is ranked lower than
82% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. AMS: -4.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AMS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -37.4  Med: -3.1 Max: 44.2
Current: -4.3
-37.4
44.2
3-Year EBITDA Growth Rate 4.20
AMS's 3-Year EBITDA Growth Rate is ranked lower than
61% of the 169 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. AMS: 4.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
AMS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -46.4  Med: -0.3 Max: 147.4
Current: 4.2
-46.4
147.4
GuruFocus has detected 1 Warning Sign with American Shared Hospital Services $AMS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» AMS's 30-Y Financials

Financials (Next Earnings Date: 2017-08-15 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621999    SIC: 8071
Compare:OTCPK:JRSS, OTCPK:HPHW, AMEX:SSY, OTCPK:CVHIF, OTCPK:BNKL, OTCPK:LMNK, OTCPK:BICX, OTCPK:PFHO, OTCPK:ARPC, OTCPK:AGHEF, OTCPK:QNIIF, OTCPK:CAMDF, OTCPK:WNDM, OTCPK:MIHI, OTCPK:BRRZF, OTCPK:SPIN, OTCPK:CCEL, OTCPK:FCHS, OTCPK:ATMS, OTCPK:USNU » details
Traded in other countries:AZS.Germany,
Headquarter Location:USA
American Shared Hospital Services provides technology solutions for advanced radiosurgical and radiation therapy services. The company also provides Gamma Knife radiosurgery equipment, and offers IGRT and IMRT systems, as well as proton therapy equipment.

American Shared Hospital Services was incorporated in the State of California in 1983 and its predecessor, Ernest A. Bates, M.D., Ltd. (d/b/a American Shared Hospital Services), a California limited partnership, was formed in June 1980. It provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to seventeen (17) medical centers in sixteen (16) states in the United States and two medical centers in Turkey, as of March 1, 2013. The Gamma Knife stereotactic radiosurgery is a non-invasive procedure and an alternative to conventional brain surgery or can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually involves shorter patient hospitalization, lower risk of complications and can be provided at a lower cost. Typically, Gamma Knife patients resume their pre-surgical activities one or two days after treatment. The Gamma Knife treats patients with 201 single doses of gamma rays that are focused with great precision on small and medium sized, well circumscribed and critically located structures in the brain. During 2006 Elekta introduced a new Gamma Knife model, the Perfexion unit, which treats patients with 192 single doses of gamma rays and will also provide the ability to perform procedures on areas of the upper cervical spine. The Gamma Knife delivers a concentrated dose of gamma rays from Cobalt-60 sources housed in the Gamma Knife. The Cobalt-60 sources converge at the target area and deliver a dose that is high enough to destroy the diseased tissue without damaging surrounding healthy tissue. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). Research is being conducted to determine whether the Gamma Knife can be effective in the treatment of epilepsy and other functional disorders. Conventional neurosurgery, radiation therapy and other radiosurgery devices are the primary competitors of Gamma Knife radiosurgery. The Medicare program is administered by the Centers for Medicare and Medicaid Services of the U.S. Department of Health and Human Services.

Top Ranked Articles about American Shared Hospital Services

David Swensen Sells 5 Holdings, Buys 2 Others An overview of the guru's 1st-quarter trades
David Swensen (Trades, Portfolio) is responsible for managing Yale University's endowment assets and investment funds. He manages a portfolio of six stocks worth $495 million. During the first quarter, the guru traded shares in the following stocks: Read more...

Ratios

vs
industry
vs
history
PE Ratio 18.09
AMS's PE Ratio is ranked higher than
71% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 25.92 vs. AMS: 18.09 )
Ranked among companies with meaningful PE Ratio only.
AMS' s PE Ratio Range Over the Past 10 Years
Min: 9.11  Med: 23.92 Max: 406.25
Current: 18.09
9.11
406.25
PE Ratio without NRI 18.09
AMS's PE Ratio without NRI is ranked higher than
75% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 26.11 vs. AMS: 18.09 )
Ranked among companies with meaningful PE Ratio without NRI only.
AMS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.11  Med: 23.92 Max: 400
Current: 18.09
9.11
400
Price-to-Owner-Earnings 5.99
AMS's Price-to-Owner-Earnings is ranked higher than
93% of the 107 Companies
in the Global Medical Care industry.

( Industry Median: 26.64 vs. AMS: 5.99 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AMS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.09  Med: 6.63 Max: 114.58
Current: 5.99
2.09
114.58
PB Ratio 0.99
AMS's PB Ratio is ranked higher than
88% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. AMS: 0.99 )
Ranked among companies with meaningful PB Ratio only.
AMS' s PB Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.66 Max: 1.77
Current: 0.99
0.26
1.77
PS Ratio 1.12
AMS's PS Ratio is ranked higher than
68% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. AMS: 1.12 )
Ranked among companies with meaningful PS Ratio only.
AMS' s PS Ratio Range Over the Past 10 Years
Min: 0.24  Med: 0.76 Max: 1.64
Current: 1.12
0.24
1.64
Price-to-Free-Cash-Flow 3.61
AMS's Price-to-Free-Cash-Flow is ranked higher than
97% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 24.52 vs. AMS: 3.61 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AMS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.87  Med: 2.37 Max: 56
Current: 3.61
0.87
56
Price-to-Operating-Cash-Flow 2.60
AMS's Price-to-Operating-Cash-Flow is ranked higher than
97% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 14.98 vs. AMS: 2.60 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AMS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.59  Med: 1.77 Max: 4.22
Current: 2.6
0.59
4.22
EV-to-EBIT 9.41
AMS's EV-to-EBIT is ranked higher than
90% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 20.37 vs. AMS: 9.41 )
Ranked among companies with meaningful EV-to-EBIT only.
AMS' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.9  Med: 13.6 Max: 75.6
Current: 9.41
6.9
75.6
EV-to-EBITDA 4.33
AMS's EV-to-EBITDA is ranked higher than
95% of the 226 Companies
in the Global Medical Care industry.

( Industry Median: 15.18 vs. AMS: 4.33 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.9  Med: 5 Max: 7.2
Current: 4.33
2.9
7.2
Shiller PE Ratio 1219.68
AMS's Shiller PE Ratio is ranked lower than
100% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 28.86 vs. AMS: 1219.68 )
Ranked among companies with meaningful Shiller PE Ratio only.
AMS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 2.44  Med: 11.92 Max: 1280.67
Current: 1219.68
2.44
1280.67
Current Ratio 1.04
AMS's Current Ratio is ranked lower than
66% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. AMS: 1.04 )
Ranked among companies with meaningful Current Ratio only.
AMS' s Current Ratio Range Over the Past 10 Years
Min: 0.12  Med: 1.05 Max: 4.13
Current: 1.04
0.12
4.13
Quick Ratio 1.04
AMS's Quick Ratio is ranked lower than
61% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. AMS: 1.04 )
Ranked among companies with meaningful Quick Ratio only.
AMS' s Quick Ratio Range Over the Past 10 Years
Min: 0.12  Med: 1.02 Max: 4.13
Current: 1.04
0.12
4.13
Days Sales Outstanding 91.95
AMS's Days Sales Outstanding is ranked lower than
90% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. AMS: 91.95 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.01  Med: 79.54 Max: 93.87
Current: 91.95
67.01
93.87
Days Payable 16.00
AMS's Days Payable is ranked lower than
78% of the 165 Companies
in the Global Medical Care industry.

( Industry Median: 44.51 vs. AMS: 16.00 )
Ranked among companies with meaningful Days Payable only.
AMS' s Days Payable Range Over the Past 10 Years
Min: 7.13  Med: 12.43 Max: 21.73
Current: 16
7.13
21.73

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -5.90
AMS's 3-Year Average Share Buyback Ratio is ranked lower than
65% of the 142 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. AMS: -5.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -18.5  Med: -1.4 Max: 8
Current: -5.9
-18.5
8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 0.99
AMS's Price-to-Tangible-Book is ranked higher than
91% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 3.78 vs. AMS: 0.99 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AMS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.27  Med: 0.77 Max: 5.96
Current: 0.99
0.27
5.96
Price-to-Intrinsic-Value-Projected-FCF 0.44
AMS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
96% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 1.96 vs. AMS: 0.44 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AMS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.04  Med: 0.25 Max: 0.54
Current: 0.44
0.04
0.54
Price-to-Median-PS-Value 1.46
AMS's Price-to-Median-PS-Value is ranked lower than
77% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 1.07 vs. AMS: 1.46 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AMS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.04  Med: 0.88 Max: 3.06
Current: 1.46
0.04
3.06
Price-to-Graham-Number 0.89
AMS's Price-to-Graham-Number is ranked higher than
90% of the 136 Companies
in the Global Medical Care industry.

( Industry Median: 2.51 vs. AMS: 0.89 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AMS' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.09  Med: 0.97 Max: 3.29
Current: 0.89
0.09
3.29
Earnings Yield (Greenblatt) % 10.63
AMS's Earnings Yield (Greenblatt) % is ranked higher than
92% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.89 vs. AMS: 10.63 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AMS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.3  Med: 7.3 Max: 14.4
Current: 10.63
1.3
14.4
Forward Rate of Return (Yacktman) % 15.54
AMS's Forward Rate of Return (Yacktman) % is ranked higher than
68% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: 10.95 vs. AMS: 15.54 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AMS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 8.5  Med: 22.9 Max: 57
Current: 15.54
8.5
57

More Statistics

Revenue (TTM) (Mil) $19.38
EPS (TTM) $ 0.21
Beta0.84
Short Percentage of Float0.28%
52-Week Range $1.81 - 5.00
Shares Outstanding (Mil)5.71
» More Articles for AMS

Headlines

Articles On GuruFocus.com
David Swensen Sells 5 Holdings, Buys 2 Others Jun 06 2017 
American Shared Hospital Services: Can a Gamma Knife Generate Alpha? Apr 30 2012 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 15 2010 
American Shared Hospital Services (AMS) CHAIRMAN AND CEO, 10% Owner Shared Hospital Services America Sep 14 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 16 2010 
American Shared Hospital Services Reports Operating Results (10-Q) May 17 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 16 2009 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 14 2009 
American Shared Hospital Services Reports Operating Results (10-Q) May 15 2009 

More From Other Websites
American Shared Hospital Services :AMS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 Jun 06 2017
American Shared Hospital Services Announces Annual Meeting Date May 24 2017
Edited Transcript of AMS earnings conference call or presentation 15-May-17 7:00pm GMT May 21 2017
American Shared Hospital Services Reports Higher First Quarter Revenue and Net Income May 15 2017
American Shared Hospital Services Announces First Quarter 2017 Results Earnings Conference Call May 11 2017
ETFs with exposure to American Shared Hospital Services : April 25, 2017 Apr 25 2017
S.Africa's Sibanye shareholders approve $2.2 bln Stillwater takeover Apr 25 2017
Book a private jet on your smartphone — for less than a first-class flight Apr 23 2017
Zimbabwe's Mugabe impatient over pace of mining reform Apr 18 2017
American Shared Hospital Services :AMS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 29,... Mar 29 2017
American Shared Hospital Services: Strong price momentum but will it sustain? Mar 24 2017
American Shared Hospital Services Fourth Quarter Net Income Increased 63.2% as Revenue Increased... Mar 23 2017
CORRECTING and REPLACING American Shared Hospital Services to Hold Conference Call to Discuss Fourth... Mar 21 2017
American Shared Hospital Services Announces Contract to Supply a Gamma Knife Perfexion System to... Mar 02 2017
Travelport's Investments Support a Narrow Moat Feb 27 2017
Sibanye looking for another South African asset Feb 06 2017
ETFs with exposure to American Shared Hospital Services : January 11, 2017 Jan 11 2017
South Africa's Sibanye pays $2.2 bln for Stillwater in U.S. move Dec 09 2016
American Shared Hospital Services :AMS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11,... Nov 11 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}